Literature DB >> 18958573

Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.

Flavio Nobili1, Giovanni B Frisoni, Florence Portet, Frans Verhey, Guido Rodriguez, Anna Caroli, Jacques Touchon, Piero Calvini, Silvia Morbelli, Fabrizio De Carli, Ugo P Guerra, Laura A Van de Pol, Pieter-Jelle Visser.   

Abstract

The Development of Screening Guidelines and Clinical Criteria of Predementia Alzheimer's Disease (DESCRIPA) multicenter study enrolled patients with MCI or subjective cognitive complaints (SUBJ), a part of whom underwent optional brain perfusion SPECT. These patients were classified as SUBJ (n = 23), nonamnestic MCI (naMCI; n = 17) and amnestic MCI (aMCI; n = 40) based on neuropsychology. Twenty healthy subjects formed the control (CTR) group. Volumetric regions of interest (VROI) analysis was performed in six associative cortical areas in each hemisphere. ANOVA for repeated measures, corrected for age and center, showed significant differences between groups (p = 0.01) and VROI (p < 0.0001) with a significant group-region interaction (p = 0.029). In the post hoc comparison, SUBJ did not differ from CTR. aMCI disclosed reduced uptake in the left hippocampus and bilateral temporal cortex (compared with CTR) or in the left hippocampus and bilateral parietal cortex (compared with SUBJ). In the naMCI group, reduced VROI values were found in the bilateral temporal cortex and right frontal cortex. In the comparison between aMCI and naMCI, the former had lower values in the left parietal cortex and precuneus. Discriminant analysis between SUBJ/CTR versus all MCI patients allowed correct allocations in 73 % of cases. Mean VROI values were highly correlated (p < 0.0001) with the learning measure of a verbal memory test, especially in the bilateral precunei and parietal cortex and in the left hippocampus. In a subset of 70 patients, mean VROI values showed a significant correlation (p < 0.05) with the white matter hyperintensities score on MRI. In conclusion, MCI subtypes have different perfusion patterns. The aMCI group exhibited a pattern that is typical of early Alzheimer's disease, while the naMCI group showed a more anterior pattern of hypoperfusion. Instead, a homogeneous group effect was lacking in SUBJ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958573     DOI: 10.1007/s00415-008-0897-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

Authors:  Flavio Nobili; Andrea Brugnolo; Piero Calvini; Francesco Copello; Caterina De Leo; Nicola Girtler; Silvia Morbelli; Arnoldo Piccardo; Paolo Vitali; Guido Rodriguez
Journal:  Clin Neurophysiol       Date:  2005-02       Impact factor: 3.708

2.  Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

Authors:  B Borroni; D Anchisi; B Paghera; B Vicini; N Kerrouche; V Garibotto; A Terzi; L A Vignolo; M Di Luca; R Giubbini; A Padovani; D Perani
Journal:  Neurobiol Aging       Date:  2005-03-24       Impact factor: 4.673

3.  FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.

Authors:  Gaël Chételat; Francis Eustache; Fausto Viader; Vincent De La Sayette; Alice Pélerin; Florence Mézenge; Didier Hannequin; Benoît Dupuy; Jean-Claude Baron; Béatrice Desgranges
Journal:  Neurocase       Date:  2005-02       Impact factor: 0.881

4.  Distinguishing normal and demented elderly with the selective reminding test.

Authors:  D M Masur; P A Fuld; A D Blau; L J Thal; H S Levin; M K Aronson
Journal:  J Clin Exp Neuropsychol       Date:  1989-10       Impact factor: 2.475

5.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

6.  Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients.

Authors:  Thaís S C Minett; Jennie L Dean; Michael Firbank; Philip English; John T O'Brien
Journal:  Am J Geriatr Psychiatry       Date:  2005-08       Impact factor: 4.105

7.  Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.

Authors:  Anna Caroli; Cristina Testa; Cristina Geroldi; Flavio Nobili; Ugo P Guerra; Matteo Bonetti; Giovanni B Frisoni
Journal:  J Neurol       Date:  2007-03-20       Impact factor: 4.849

8.  Stability of neurocognitive impairment in different subtypes of mild cognitive impairment.

Authors:  David A Loewenstein; Amarilis Acevedo; Joscelyn Agron; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2006-11-22       Impact factor: 2.959

9.  Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy.

Authors:  O Sabri; E B Ringelstein; D Hellwig; R Schneider; M Schreckenberger; H J Kaiser; M Mull; U Buell
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

10.  Discordance of technetium-99m-HMPAO and technetium-99m-ECD SPECT in herpes simplex encephalitis.

Authors:  H Rieck; C Adelwöhrer; K Lungenschmid; E Deisenhammer
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057

View more
  20 in total

1.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Georgina Vinyes-Junqué; Mercè Boada; Pablo Martínez-Lage; Gemma Cuberas; Ana Espinosa; Isabel Roca; Isabel Hernández; Sergi Valero; Maitée Rosende-Roca; Ana Mauleón; James T Becker And; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings.

Authors:  Bliss Elizabeth O'Bryhim; Rajendra S Apte; Nathan Kung; Dean Coble; Gregory P Van Stavern
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

4.  Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial.

Authors:  Hsien-Yuan Lane; Cheng-Hao Tu; Wei-Che Lin; Chieh-Hsin Lin
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

5.  Asymmetric cerebral blood flow in patients with mild cognitive impairment: possible relationship to further cognitive deterioration.

Authors:  Ake Edman; Lars Edenbrandt; Johan Fredén-Lindqvist; Magnus Nilsson; Anders Wallin
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-07-29

Review 6.  What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.

Authors:  Cesar Reis; Yuechun Wang; Onat Akyol; Wing Mann Ho; Richard Applegate Ii; Gary Stier; Robert Martin; John H Zhang
Journal:  Int J Mol Sci       Date:  2015-05-26       Impact factor: 5.923

7.  Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.

Authors:  Artur M N Coutinho; Fábio H G Porto; Fabio L S Duran; Silvana Prando; Carla R Ono; Esther A A F Feitosa; Lívia Spíndola; Maira O de Oliveira; Patrícia H F do Vale; Helio R Gomes; Ricardo Nitrini; Sonia M D Brucki; Carlos A Buchpiguel
Journal:  Alzheimers Res Ther       Date:  2015-09-15       Impact factor: 6.982

8.  Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Authors:  Jean-Paul Soucy; Robert Bartha; Christian Bocti; Michael Borrie; Amer M Burhan; Robert Laforce; Pedro Rosa-Neto
Journal:  Alzheimers Res Ther       Date:  2013-07-08       Impact factor: 6.982

Review 9.  Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer's disease.

Authors:  Kamil Vlček; Jan Laczó
Journal:  Front Behav Neurosci       Date:  2014-03-17       Impact factor: 3.558

Review 10.  Clinical utility of SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: a systematic review.

Authors:  Cyrus A Raji; Robert Tarzwell; Dan Pavel; Howard Schneider; Michael Uszler; John Thornton; Muriel van Lierop; Phil Cohen; Daniel G Amen; Theodore Henderson
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.